8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed May 2, 2024 · 2y ago · Accession 0001558370-24-006459
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRESCENT BIOPHARMA, INC.
- Ticker
- CBIO
- CIK
- 1253689
- Form type
- 8-K
- Filing date
- May 2, 2024
- Report date
- May 1, 2024
- Document
- glyc-20240501x8k.htm
- Size
- 313 KB